High-performance liquid chromatographic assay for glucuronidation activityof 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in human liver microsomes
N. Hanioka et al., High-performance liquid chromatographic assay for glucuronidation activityof 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in human liver microsomes, BIOMED CHRO, 15(5), 2001, pp. 328-333
A simple and sensitive assay for glucuronidation activity of 7-ethyl-10-hyd
roxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11). in
human liver microsomes by high-performance liquid chromatography (HPLC) wit
h fluorescence detection is reported. The method was validated for the dete
rmination of SN-38 glucuronide (SN-38G) with respect to specificity, linear
ity, recovery, stability, precision, accuracy, and limits of detection and
quantitation. There was no interference from matrix and non-enzymatic react
ions. The calibration curve for SN-38G was linear from 5 to 500 nm. Average
recoveries ranged from 98 to 100% in spiked human liver microsome samples,
and the SN-38G was stable at 4 degreesC for at least 72 h. The newly devel
oped method was found to be more sensitive and selective than previous meth
ods using thin layer chromatography and HPI-C. The limit of quantitation fo
r SN-38G was 5 nm (2.5 pmol/assay). The intra- and inter-day precision and
accuracy were less than 7 and 4%. respectively. The intra- and inter-day pr
ecision of enzyme assay for UDP-glucuronosyltransferase (UGT) activity towa
rd SN-38 in human liver microsomes was less than 4%. With this improved sen
sitivity, the kinetics of SN-38 glucuronidation in human liver microsomes c
ould be determined more precisely. Therefore, this method is applicable to
in vitro study on the side effects and drug interactions of CPT-11 using sm
all amounts of biological sample. Copyright (C) 2001 John Wiley & Sons, Ltd
.